U.S. FDA’s Response To Heparin Scare Made With “Alacrity And Sound Judgment” – von Eschenbach

In a Feb. 15 e-mail to agency personnel, U.S. FDA Commissioner Andrew von Eschenbach said the U.S. FDA has responded to the recent import safety scare related to Baxter Healthcare's injectable heparin "with its customary alacrity and sound judgment.